investordatabase.org

SR One

srone.com Direct investor

SR One is a transatlantic biotechnology venture capital firm that partners with founders to translate innovative science into medicines. It invests in companies with strong fundamentals and novel approaches to diseases, with teams in the US and UK.

SR One is a venture capital firm headquartered in Redwood City, United States. It invests directly in companies, from pre-seed to growth, in biotechnology, pharmaceuticals and healthcare.

“Focusing on companies that we believe have strong underlying fundamentals, a clearly defined development pathway, and novel approaches to addressing diseases, SR One aims to help reimagine today’s science for tomorrow’s medicines.”

— SR One, own website
Layer
Direct investor
Type
Venture capital
Stage
Pre-seed – Growth
Headquarters
Redwood City, United States
Invests in
US, UK, Europe
Sectors
biotechnology, pharmaceuticals, healthcare

Team, as SR One publishes it

  • Simeon J. George, MD Founder & CEO
  • Rajeev Dadoo, PhD COO & Managing Partner
  • Jake Nunn Partner
  • Philip Habib Head of Capital Partnering
  • Sasha Keough General Counsel & Chief Compliance Officer
  • Mahesh Kudari, MD Senior Associate
  • James Macadam Chief Financial Officer
  • Katarina Pance, PhD Principal
  • Laetitia Schwab, PhD Principal
  • Amit Shah, MD Principal
  • Lyla Youssef, PhD Associate
  • Jake Bauer Venture Partner

Names and roles exactly as listed on srone.com. Nothing else about these people is recorded.

Co-invests most often with

Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 44 co-investors found.

  • OrbiMed 9 shared companies: charmtx.com, ars-pharma.com, windwardbio.com, alumis.com…
  • Longwood Fund 4 shared companies: avenzotx.com, bicycletherapeutics.com, crystalystx.com, pulmocide.com
  • Atlas Venture 3 shared companies: hotspotthera.com, nimbustx.com, sperotherapeutics.com
  • IP Group plc 3 shared companies: missiontherapeutics.com, akamisbio.com, pulmocide.com
  • F-Prime Capital 3 shared companies: immutrin.com, avalynpharma.com, charmtx.com
  • Frazier Life Sciences Management, LP 3 shared companies: immutrin.com, airnexis.com, crystalystx.com
  • RA Capital Management 3 shared companies: sperotherapeutics.com, ars-pharma.com, windwardbio.com
  • Longitude Capital 3 shared companies: airnexis.com, veradermics.com, zenasbio.com
  • Sofinnova 2 shared companies: hotspotthera.com, missiontherapeutics.com
  • Avoro Capital Advisors LLC 2 shared companies: crisprtx.com, designtx.com

and 34 more — the graph.

Limited partners that disclose a commitment

From the LP's own published fund list — the LP is the source, not the manager.

Where this comes from

Every fact above was read from a page SR One publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 1721 · added 2026-08-28 · link last verified 2026-09-06 · confidence high

Similar investors

Listed under